Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.38 |
| ▸ | CCR8 | P51685 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12035969 | 0.82 | FFAR4 (0.39) | DHFRHTR2AFFAR4KMT2AKDM5A | |
| SCHEMBL12035983 | 0.82 | FFAR4 (0.39) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL2437696 | 0.81 | FFAR4 (0.38) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL12035998 | 0.81 | HTR2A (0.39) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL12056189 | 0.81 | FFAR4 (0.38) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL12035510 | 0.81 | FFAR4 (0.54) | DHFRHTR2AFFAR4 | |
| SCHEMBL12035976 | 0.79 | DHFR (0.45) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL12036054 | 0.78 | FFAR4 (0.39) | DHFRHTR2AFFAR4KMT2AKDM5A | |
| SCHEMBL12035992 | 0.78 | FFAR4 (0.37) | DHFRHTR2AFFAR4KMT2ALMNA | |
| SCHEMBL9983136 | 0.76 | GAA (0.36) | DHFRHTR2AFFAR4KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367793-B1 | GPR120 RECEPTOR AGONISTS AND USES THEREOF | METABOLEX INC (US) | 2013-03-27 | — | — | EP | disclosed |